You are not logged in.

Patient costs during tuberculosis treatment in Bangladesh and Tanzania: the potential of shorter regimens

Gospodarevskaya,E, Tulloch,O, Bunga,C, Ferdous,S, Jonas,A, Islam,S, Rahman,M, Hussain,MA, Haque,MN, Egwaga,S, Gardiner,E, PrayGod,G, Islam,MA, Mann,GH, Wells,WA and Squire,SB 2014, Patient costs during tuberculosis treatment in Bangladesh and Tanzania: the potential of shorter regimens, International journal of tuberculosis and lung disease, vol. 18, no. 7, pp. 810-817, doi: 10.5588/ijtld.13.0391.

Attached Files
Name Description MIMEType Size Downloads

Title Patient costs during tuberculosis treatment in Bangladesh and Tanzania: the potential of shorter regimens
Author(s) Gospodarevskaya,E
Tulloch,O
Bunga,C
Ferdous,S
Jonas,A
Islam,S
Rahman,M
Hussain,MA
Haque,MN
Egwaga,S
Gardiner,E
PrayGod,G
Islam,MA
Mann,GH
Wells,WA
Squire,SB
Journal name International journal of tuberculosis and lung disease
Volume number 18
Issue number 7
Start page 810
End page 817
Publisher International Union against Tuberculosis and Lung Disease
Place of publication Paris, France
Publication date 2014-07
ISSN 1027-3719
Keyword(s) Access
Patient preferences
Poverty
Treatment costs
Summary OBJECTIVE: To estimate the costs incurred by patients during the intensive and continuation phases of the current 6-month tuberculosis (TB) regimen in Bangladesh and Tanzania, and thus identify potential benefits to patients of a shorter, 4-month treatment regimen. DESIGN: The validated Stop TB patient cost questionnaire was adapted and used in interviews with 190 patients in the continuation phase of treatment with current regimens. RESULTS: In both countries, overall patient costs were lower during 2 months of the continuation phase (US$74 in Tanzania and US$56 in Bangladesh) than during the 2 months of the intensive phase of treatment (US$150 and US$111, respectively). However, continuation phase patient costs still represented 89% and 77% of the 2-month average national income in the respective countries. Direct travel costs in some settings were kept low by local delivery system features such as community treatment observation. Lost productivity and costs for supplementary foods remained significant. CONCLUSIONS: Although it is not a straightforward exercise to determine the exact magnitude of likely savings, a shorter regimen would reduce out-of-pocket expenses incurred by patients in the most recent 2 months of the continuation phase and allow an earlier return to productive activities. © 2014 The Union.
Language eng
DOI 10.5588/ijtld.13.0391
Field of Research 111708 Health and Community Services
Socio Economic Objective 920407 Health Protection and/or Disaster Response
HERDC Research category C1.1 Refereed article in a scholarly journal
ERA Research output type C Journal article
Copyright notice ©2014, International Union against Tuberculosis and Lung Disease
Persistent URL http://hdl.handle.net/10536/DRO/DU:30069876

Document type: Journal Article
Collection: Population Health
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 15 times in TR Web of Science
Scopus Citation Count Cited 11 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 79 Abstract Views, 2 File Downloads  -  Detailed Statistics
Created: Thu, 19 Feb 2015, 12:29:59 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.